Sauvie

Sauvie Inc. is a biopharmaceutical company founded by UnionVille Capital LLC in 2022, focusing on the development and commercialization of immuno-oncology therapies that are crucial for cancer patients. The company plans to continuously expand key cancer therapies through strategic acquisitions, collaborations, research and development, and commercialization, thereby creating substantial value.